- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Strategy for drug discovery research in Astellas Pharma Inc.
-
- Iwai Akihiko
- Astellas Pharma Inc.
Bibliographic Information
- Other Title
-
- アステラス製薬の創薬研究戦略
Search this article
Description
<p>In order to continually create high-value medical solutions for society and patients, it is essential to utilize the advancement of cutting-edge science for drug discovery research, and to have an appropriate mechanism to realize this goal. At Astellas Pharma Inc., we encompass various kinds of scientific progress as opportunities for the creation of new drugs and are continually challenging to drug discovery research from a multiple approach perspective, considering the three elements of “disease”, “biology”, and “modality & technology”. In addition, we define Focus Areas from these three elements and implement drug discovery research by expanding and redefining our Focus Areas. Our internal HR system to promote innovation creation is also very important. In this paper, I would like to share ideas about the traits of the innovative drug discovery researchers of the future.</p>
Journal
-
- MEDCHEM NEWS
-
MEDCHEM NEWS 29 (2), 50-53, 2019-05-01
The Pharmaceutical Society of Japan
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390005667266907904
-
- NII Article ID
- 130007981751
-
- ISSN
- 24328626
- 24328618
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed